MediciNova, Inc.
JPX: 4875.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Yuichi Iwaki
- Employees
- 13
- Headquarters
- La Jolla, United States
- IPO year
- 2007
- Market cap
- ¥10.9B
- Website
- https://www.medicinova.com
Loading 4875…
Loading profile data…Frequently asked questions about 4875
What does MediciNova, Inc. (4875.T) do?
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and...
Where does 4875.T trade?
MediciNova, Inc. (4875.T) trades on the Tokyo Stock Exchange.
What sector is 4875.T in?
MediciNova, Inc. (4875.T) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of MediciNova, Inc.?
Yuichi Iwaki is the chief executive officer of MediciNova, Inc. (4875.T).
Where is MediciNova, Inc. headquartered?
MediciNova, Inc. is headquartered in United States.
Does 4875.T pay a dividend?
MediciNova, Inc. (4875.T) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 4875.T go public?
MediciNova, Inc. (4875.T) completed its initial public offering in 2007.